Infertility/Sterility
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Cetrorelix Acetate
Research Leaders
6 sponsors active, led by University College Hospital, Ibadan, Nigeria
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Positive Adjustment Coping Intervention
Fertility Life Counselling Aid- FeLiCiA
Markers in Follicular Fluid and in Embryo Culture Medium as a Marker of Oocyte and Embryo Quality
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
Research Network
Common Treatments
- Cetrorelix Acetate1
- Ganirelix Acetate1
- Brainteaser1
- Fertility Life Counselling Aid Felicia1
- Positive Adjustment Coping Intervention1
Active Sponsors
- University College Hospital, Ibadan, Nigeria1
- University of Liverpool1
- Andrew Weeks MD MRCOG1
- University Hospital Heidelberg1
- Università degli Studi 'G. d'Annunzio' Chieti e Pescara1
Top Investigators
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
University Hospital Heidelberg
University of Liverpool
Carmel Medical Center
Related Conditions
- Psychological Stress1
- Psychological Distress1
- Anxiety Disorders1
- Depressive Disorder1